Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAC: Sofosbuvir-based Regimens for Hepatitis C in Africa
NCT02405013Phase 2Completed
- Sponsor
- ANRS
- Start
- Oct 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of sofosbuvir in hepatitis C (HCV), sponsored by ANRS. Started Oct 2015; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02405013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02405013.